United Therapeutics Statistics
Total Valuation
UTHR has a market cap or net worth of $16.05 billion. The enterprise value is $11.85 billion.
| Market Cap | 16.05B |
| Enterprise Value | 11.85B |
Important Dates
The next estimated earnings date is Wednesday, February 19, 2025, before market open.
| Earnings Date | Feb 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTHR has 44.64 million shares outstanding. The number of shares has decreased by -1.36% in one year.
| Current Share Class | 44.64M |
| Shares Outstanding | 44.64M |
| Shares Change (YoY) | -1.36% |
| Shares Change (QoQ) | +1.89% |
| Owned by Insiders (%) | 1.77% |
| Owned by Institutions (%) | 93.12% |
| Float | 40.93M |
Valuation Ratios
The trailing PE ratio is 15.82 and the forward PE ratio is 12.40. UTHR's PEG ratio is 1.04.
| PE Ratio | 15.82 |
| Forward PE | 12.40 |
| PS Ratio | 5.97 |
| Forward PS | 5.03 |
| PB Ratio | 2.63 |
| P/TBV Ratio | 2.68 |
| P/FCF Ratio | 17.87 |
| P/OCF Ratio | 14.12 |
| PEG Ratio | 1.04 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.39, with an EV/FCF ratio of 13.19.
| EV / Earnings | 10.66 |
| EV / Sales | 4.30 |
| EV / EBITDA | 8.39 |
| EV / EBIT | 8.80 |
| EV / FCF | 13.19 |
Financial Position
The company has a current ratio of 4.58, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.58 |
| Quick Ratio | 4.20 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.45 |
| Interest Coverage | 26.86 |
Financial Efficiency
Return on equity (ROE) is 18.81% and return on invested capital (ROIC) is 12.93%.
| Return on Equity (ROE) | 18.81% |
| Return on Assets (ROA) | 11.89% |
| Return on Capital (ROIC) | 12.93% |
| Revenue Per Employee | $2.36M |
| Profits Per Employee | $951,113 |
| Employee Count | 1,168 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.43 |
Taxes
In the past 12 months, UTHR has paid $327.00 million in taxes.
| Income Tax | 327.00M |
| Effective Tax Rate | 22.74% |
Stock Price Statistics
The stock price has increased by +49.66% in the last 52 weeks. The beta is 0.55, so UTHR's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +49.66% |
| 50-Day Moving Average | 370.64 |
| 200-Day Moving Average | 316.31 |
| Relative Strength Index (RSI) | 43.55 |
| Average Volume (20 Days) | 313,570 |
Short Selling Information
The latest short interest is 2.08 million, so 4.66% of the outstanding shares have been sold short.
| Short Interest | 2.08M |
| Short Previous Month | 2.21M |
| Short % of Shares Out | 4.66% |
| Short % of Float | 5.09% |
| Short Ratio (days to cover) | 5.67 |
Income Statement
In the last 12 months, UTHR had revenue of $2.76 billion and earned $1.11 billion in profits. Earnings per share was $22.72.
| Revenue | 2.76B |
| Gross Profit | 2.45B |
| Operating Income | 1.35B |
| Pretax Income | 1.40B |
| Net Income | 1.11B |
| EBITDA | 1.41B |
| EBIT | 1.35B |
| Earnings Per Share (EPS) | $22.72 |
Balance Sheet
The company has $3.33 billion in cash and $400.00 million in debt, giving a net cash position of $4.21 billion or $94.21 per share.
| Cash & Cash Equivalents | 3.33B |
| Total Debt | 400.00M |
| Net Cash | 4.21B |
| Net Cash Per Share | $94.21 |
| Equity (Book Value) | 6.10B |
| Book Value Per Share | 136.74 |
| Working Capital | 3.13B |
Cash Flow
In the last 12 months, operating cash flow was $1.14 billion and capital expenditures -$238.50 million, giving a free cash flow of $898.10 million.
| Operating Cash Flow | 1.14B |
| Capital Expenditures | -238.50M |
| Free Cash Flow | 898.10M |
| FCF Per Share | $20.12 |
Margins
Gross margin is 88.94%, with operating and profit margins of 48.82% and 40.31%.
| Gross Margin | 88.94% |
| Operating Margin | 48.82% |
| Pretax Margin | 52.17% |
| Profit Margin | 40.31% |
| EBITDA Margin | 51.23% |
| EBIT Margin | 48.82% |
| FCF Margin | 32.58% |
Dividends & Yields
UTHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.36% |
| Shareholder Yield | 1.36% |
| Earnings Yield | 6.92% |
| FCF Yield | 5.59% |
Analyst Forecast
The average price target for UTHR is $370.86, which is 3.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $370.86 |
| Price Target Difference | 3.14% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 9.84% |
| EPS Growth Forecast (5Y) | 12.02% |
Stock Splits
The last stock split was on September 23, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 23, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
UTHR has an Altman Z-Score of 10.01 and a Piotroski F-Score of 6.
| Altman Z-Score | 10.01 |
| Piotroski F-Score | 6 |